Update on activity of dalbavancin and comparators against clinical isolates of Gram-positive pathogens from Europe and Russia (2017-2018), and on clonal distribution of MRSA.

Riccobono, Eleonora; Giani, Tommaso; Baldi, Giulia; Arcangeli, Sophie; Antonelli, Alberto; Tellone, Valeria; Del Vecchio, Alessandra; De Joannon, Alessandra Capezzone; Rossolini, Gian Maria

Riccobono, Eleonora; Giani, Tommaso; Baldi, Giulia; Arcangeli, Sophie; Antonelli, Alberto; Tellone, Valeria; Del Vecchio, Alessandra; De Joannon, Alessandra Capezzone; Rossolini, Gian Maria.

Afiliación

Riccobono E; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Giani T; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; Clinical Microbiology and Virology Unit, Careggi University Hospital, Florence, Italy.
Baldi G; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Arcangeli S; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Antonelli A; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; Clinical Microbiology and Virology Unit, Careggi University Hospital, Florence, Italy.
Tellone V; Angelini Pharma S.p.A., Italy.
Del Vecchio A; Angelini Pharma S.p.A., Italy.
De Joannon AC; Angelini Pharma S.p.A., Italy.
Rossolini GM; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; Clinical Microbiology and Virology Unit, Careggi University Hospital, Florence, Italy. Electronic address: gianmaria.rossolini@unifi.it.

Int J Antimicrob Agents ; 59(2): 106503, 2022 Feb.

Article en En | MEDLINE | ID: mdl-34929289

Asunto(s)

Infecciones por Bacterias Grampositivas; Staphylococcus aureus Resistente a Meticilina; Antibacterianos/farmacología; Antibacterianos/uso terapéutico; Europa (Continente); Bacterias Grampositivas; Infecciones por Bacterias Grampositivas/tratamiento farmacológico; Infecciones por Bacterias Grampositivas/microbiología; Humanos; Pruebas de Sensibilidad Microbiana; Teicoplanina/análogos & derivados; Teicoplanina/farmacología; Teicoplanina/uso terapéutico; Vancomicina/farmacología

Palabras clave

ABSSSIs; Antimicrobial activity; Dalbavancin; Gram-positive pathogens

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por Bacterias Grampositivas / Staphylococcus aureus Resistente a Meticilina Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Int J Antimicrob Agents Año: 2022 Tipo del documento: Article País de afiliación: Italia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google